What is the latest VALIANTLAB stock price?
The latest stored price for VALIANTLAB is Rs 123.33 as of 2026-11-03.
gimli
VALIANTLAB stock AI analysis
VALIANTLAB Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
VALIANT LABORATORIES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available VALIANTLAB price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹123.33
1W return
-0.02%
1M return
-1.40%
3M return
+99.76%
6M return
+58.48%
1Y return
+47.31%
Market cap
₹669.84 cr
PE
152.93
PB
2.15
ROE
+1.61%
ROCE
+7.69%
RSI
49.16
Turnover
₹0.12 cr
Why it can matter in screens
- Momentum: VALIANTLAB is above 50DMA, above 200DMA; RSI is 49.16.
- Returns: 1D -1.99%, 1W -0.02%, 1M -1.40%, 3M +99.76%, 1Y +47.31%.
- Trend levels: 52W high ₹141.38, 52W low ₹58.08, off high -12.77%.
- Liquidity: latest turnover is ₹0.12 cr; volume vs 20D is +0.17%.
- Valuation/profitability: PE 152.93, PB 2.15, ROE +1.61%, ROCE +7.69%.
- Growth: 3Y sales CAGR -10.74%, 3Y profit CAGR n/a.
Quick Answers
Is VALIANTLAB above its 50DMA and 200DMA?
VALIANTLAB is above 50DMA, above 200DMA. The latest 50DMA is 119.03 and the latest 200DMA is 79.14.
What are VALIANTLAB PE, ROE and ROCE?
VALIANTLAB has PE 152.93, ROE +1.61%, and ROCE +7.69% in Gimli's latest available snapshot.
How has VALIANTLAB performed recently?
VALIANTLAB has returned -1.40% over 1 month, +99.76% over 3 months, and +47.31% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 74.27 cr | 13.35 cr | 9.48 cr | 3.89 |
| 2026-03-31 | 91.98 cr | 4.98 cr | 1.76 cr | 0.32 |
| 2025-12-31 | 52.46 cr | -0.26 cr | -7.06 cr | -1.30 |
| 2025-09-30 | 46.20 cr | 0.94 cr | 0.20 cr | 0.04 |
| 2025-06-30 | 46.82 cr | 3.05 cr | 1.82 cr | 0.39 |
| 2025-03-31 | 57.79 cr | 1.51 cr | 0.70 cr | 0.16 |
| 2024-12-31 | 35.23 cr | 2.20 cr | n/a | nan |
| 2024-09-30 | 21.48 cr | -3.38 cr | n/a | -1.09 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 237.47 cr | 8.71 cr | -3.27 cr | nan |
| 2025-03-31 | 133.38 cr | 0.76 cr | -2.20 cr | -0.51 |
| 2024-03-31 | 182.06 cr | 1.27 cr | 0.32 cr | 0.12 |
| 2023-03-31 | 333.91 cr | 39.95 cr | 29.00 cr | 6.19 |
| 2022-03-31 | 293.47 cr | 44.27 cr | 27.50 cr | 5.87 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 463.98 cr | 3.53 cr | 46.21 cr | 310.89 cr |
| 2025-03-31 | 400.86 cr | 4.92 cr | 121.69 cr | 234.31 cr |
| 2024-03-31 | 342.69 cr | 11.72 cr | 76.71 cr | 236.86 cr |
| 2023-03-31 | 212.97 cr | 1.26 cr | 60.22 cr | 100.49 cr |
| 2022-03-31 | 181.81 cr | 0.13 cr | 61.13 cr | 71.46 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | -10.43 cr | -44.63 cr | n/a |
| 2025-03-31 | 1.31 cr | -112.54 cr | n/a |
| 2024-03-31 | 1.89 cr | -43.98 cr | n/a |
| 2023-03-31 | 56.05 cr | 18.37 cr | n/a |
| 2022-03-31 | 2.25 cr | -4.62 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +74.94% | +0.00% | +0.00% | +0.00% | +25.06% | +0.00% |
| 2026-03-31 | +74.94% | +0.20% | +0.00% | +0.00% | +24.86% | +0.00% |
| 2025-12-31 | +74.94% | +0.01% | +0.00% | +0.00% | +25.05% | +0.00% |
| 2025-09-30 | +74.94% | +0.02% | +0.00% | +0.00% | +25.04% | +0.00% |
| 2025-08-11 | +74.94% | +0.52% | +0.00% | +0.00% | +24.54% | +0.00% |
| 2025-06-30 | +74.94% | +0.63% | +0.46% | +0.00% | +23.97% | +0.00% |
| 2025-03-31 | +74.94% | +0.64% | +0.00% | +0.00% | +24.42% | +0.00% |
| 2024-12-31 | +74.94% | +0.00% | +0.00% | +0.00% | +25.06% | +0.00% |
| 2024-09-30 | +74.94% | +0.00% | +0.00% | +0.00% | +25.06% | +0.00% |
| 2024-06-30 | +74.94% | +1.89% | +0.00% | +0.00% | +23.17% | +0.00% |
| 2024-03-31 | +74.94% | +3.48% | +0.03% | +0.00% | +21.55% | +0.00% |
| 2023-12-31 | +74.94% | +7.08% | +0.47% | +0.00% | +17.51% | +0.00% |
| 2023-10-04 | +74.94% | +8.64% | +3.89% | +0.00% | +12.53% | +0.00% |
| 2023-09-30 | +74.94% | +8.64% | +3.89% | +0.00% | +12.53% | n/a |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze VALIANT LABORATORIES with valuation, momentum and industry peers
- Compare VALIANTLAB with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare VALIANTLAB with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.